DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹2,191 Cr | ₹1,600 Cr | ₹1,824 Cr | ₹2,960 Cr | ₹1,984 Cr |
What is the latest Profit After Tax of DIVIS LABORATORIES ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹2,191 Cr |
| Mar2024 | ₹1,600 Cr |
| Mar2023 | ₹1,824 Cr |
| Mar2022 | ₹2,960 Cr |
| Mar2021 | ₹1,984 Cr |
How is Profit After Tax of DIVIS LABORATORIES Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,191 Cr | 36.94 | |
| Mar2024 | ₹1,600 Cr | -12.28 | |
| Mar2023 | ₹1,824 Cr | -38.39 | |
| Mar2022 | ₹2,960 Cr | 49.19 | |
| Mar2021 | ₹1,984 Cr | - | |
Compare Profit After Tax of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹179,110.3 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
| MANKIND PHARMA | ₹98,333.5 Cr | -1.4% | -2.2% | 0.7% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 3.9% |
18.6% |
14.5% |
| SENSEX | -0.3% |
4.5% |
5.7% |
You may also like the below Video Courses